| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $-0.0B | $0.0B | $0.1B | $0.1B | $-0.0B | $0.1B | $0.0B |
| EPS (Basic) | $1.26 | $-0.44 | $0.97 | $1.87 | $3.04 | $-0.04 | $1.21 | $1.08 |
| EPS (Diluted) | $1.26 | $-0.44 | $0.96 | $1.85 | $3.01 | $-0.04 | $1.20 | $1.08 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.8B | $9.9B | $9.7B | $9.1B | $7.6B | $7.8B | $8.0B | $8.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | $0.3B | $0.2B | $0.1B | $0.1B |
| Total Liabilities | $8.8B | $9.0B | $9.0B | $8.4B | $6.8B | $7.0B | $7.2B | $7.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.9B | $0.9B | $0.7B | $0.7B | $0.8B | $0.8B | $0.8B | $0.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.0B | $-0.0B | $0.1B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.0B | $-0.6B | $-0.6B | $-1.4B | $0.4B | $0.3B | $0.2B | $0.2B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.2B | $0.8B | $0.6B | $1.5B | $-0.4B | $-0.3B | $-0.2B | $-0.3B |